Clinical trial
Progesterone vs Placebo Therapy for Women With Epilepsy
NCT00029536 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00029536 |
|---|---|
| Title | Progesterone vs Placebo Therapy for Women With Epilepsy |
| Official title | Phase 3 Study of Progesterone vs Placebo Therapy |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | Brigham and Women's Hospital Columbia University Dartmouth-Hitchcock Medical Center Emory University Johns Hopkins University Montreal Neurological Institute and Hospital Ohio State University Thomas… |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Biological, Other |
| Interventions | Progesterone Lozenges, Matched Placebo Lozenges |
| Enrollment | 294 |
| Start date | Oct 1, 2000 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Jan 16, 2002 |
| Last update posted | Jun 5, 2017 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: